LSB
LakeShore Biopharma
7 hedge funds and large institutions have $330K invested in LakeShore Biopharma in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$6.6K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$15.3K |
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$55.9K |
| 2 |
2
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
$0 |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Fidelity Investments
Boston,
Massachusetts
| $119K | 116,508 | – | – |
|
|
HA
2
HHLR Advisors
Grand Cayman,
Cayman Islands
| $76.7K | 75,179 | – | – |
|
|
O
3
OrbiMed
New York
| $55.9K | 54,799 | -85,629 | -61% |
|
|
SCM
4
Superstring Capital Management
New York
| $31.4K | 30,792 | – | – |
|
5
Barclays
London,
United Kingdom
| $25K | 24,757 | – | – |
|
|
6
Citadel Advisors
Miami,
Florida
| $15.3K | 14,963 | +4,377 | +41% |
|
|
7
UBS Group
Zurich,
Switzerland
| $6.6K | 6,469 | +5,469 | +547% |
|
|
8
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | – | -1,048,320 | Closed |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | – | -280 | Closed |
|